Novo Nordisk A/S vs Johnson & Johnson — Stock Comparison
Q·Score Breakdown
6.1
Hold
Overall
7.1
Buy
Quality
Health
Growth
Valuation
Sentiment
NVO
High-quality business with 61% return on equity and 33% profit margins.
⚠ revenue declining 8% year-over-year.
JNJ
High-quality business with 26% return on equity and 22% profit margins.
⚠ earnings contracting 53% year-over-year.
Analyst Consensus
HOLD
Target $46.65 (+9.5%)
12 analysts
BUY
Target $252.42 (+9.6%)
24 analysts
Fundamentals
NVO
JNJ
11.8×
Trailing P/E
26.6×
12.4×
Forward P/E
18.1×
33.1%
Profit Margin
21.8%
82.4%
Gross Margin
68.0%
60.7%
ROE
26.4%
-7.6%
Revenue Growth
9.9%
-4.7%
Earnings Growth
-52.9%
0.27
Beta
0.33
—
Price / Book
—
$188.9B
Market Cap
$554.3B
$35 – $81
52-Week Range
$146 – $252
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load.